Search
for
Sort by
Research 421–450 of 1000+
- Insulin Resistance in Patients with Androgenic Alpoecia”
- (101) Ovarian Hyperthecosis as a Cause of Hypersexualization in a Post-menopausal Female
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- A machine learning approach for non-invasive PCOS diagnosis from ultrasound and clinical features
- Pattern of Hyperandrogenemia in Patients with Polycystic Ovary Syndrome at a Tertiary Care Hospital
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Estimation of Dehydroepiandrosterone (DHEA) and Tumor Necrosis Factor–Alpha (TNF-α) Levels Women Diagnosed with Polycystic Syndrome
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent
- Gynecologic and andrologic dermatology and the metabolic syndrome
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Prenatal Androgenization of Ewes as a Model of Hirsutism in Polycystic Ovary Syndrome
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Ayurvedic Management of Poly Cystic Ovarian Syndrome with Clinical and Biochemical Androgen Excess and Oligo-ovulation – A Case Study
- Serum Cystatin C levels in adolescent females: A comparative study between PCOS and Non-PCOS groups
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome